Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors

Lingchao Miao,Yan Zhou,Dechao Tan,Chunxiu Zhou,Cheng-Chao Ruan,Shengpeng Wang,Yitao Wang,Chi Teng Vong,Wai San Cheang

DOI: https://doi.org/10.1039/d3fo05222b

IF: 6.3173

2024-04-19

Food & Function

Abstract:Ginsenoside Rk1, one kind of ginsenosides, is a minor ginsenoside found in Panax Ginseng and used as traditional Chinese medicine for centuries. It exhibits anti-tumor and anti-aggregation effects. However, little research has been done about its effect on endothelial function. This study investigated whether ginsenoside Rk1 improved endothelial dysfunction in diabetes and the underlying mechanisms in-vivo and in-vitro. Male C57BL/6 mice were fed with a 12-week high-fat diet (60% kcal % fat), whereas treatment groups were orally administered with ginsenoside Rk1 (10 and 20 mg/kg/day) in the last 4 weeks. Aortas isolated from C57BL/6 mice were induced by high glucose (HG; 30 mM) and co-treated with or without ginsenoside Rk1 (1 and 10 μM) for 48 h ex vivo. Moreover, primary rat aortic endothelial cells (RAECs) were cultured and stimulated by HG (44 mM) to mimic hyperglycemia, with or without co-treatment of ginsenoside Rk1 (10 μM) for 48 h. Endothelium-dependent relaxations of mouse aortas were damaged with elevated oxidative stress and downregulation of three isoforms of peroxisome proliferator-activated receptors (PPARs), PPAR-α, PPAR-β/δ, and PPAR-γ, as well as endothelial nitric oxide synthase (eNOS) phosphorylation due to HG or high-fat diet stimulation, which also existed in RAECs. However, after the treatment of ginsenoside Rk1, these impairments were all ameliorated significantly. Moreover, the vaso-protective and anti-oxidative effects of ginsenoside Rk1 were abolished by PPARs antagonists (GSK0660, GW9662 or GW6471). In conclusion, this study reveals that ginsenoside Rk1 ameliorates endothelial dysfunction and suppresses oxidative stress in diabetic vasculature through activating PPAR/eNOS pathway.

biochemistry & molecular biology,food science & technology

What problem does this paper attempt to address?

This paper mainly discusses the role and mechanism of ginsenoside Rk1 in improving vascular endothelial dysfunction in diabetes. The study found that Rk1 can inhibit the growth of human colon cancer cells induced by high glucose and reduce oxidative stress by activating the peroxisome proliferator-activated receptors (PPARs)/endothelial nitric oxide synthase (eNOS) pathway. In a diabetic mouse model, Rk1 treatment can reduce blood glucose, improve endothelium-dependent vasodilation, and upregulate the expression of PPARs subtypes (α, β/δ, and γ) as well as eNOS. Additionally, Rk1 can alleviate oxidative stress in high glucose environment and enhance antioxidant capacity by activating PPARs. However, using PPARs antagonist can counteract these protective effects of Rk1. Therefore, this paper reveals the role of Rk1 in improving vascular dysfunction and oxidative stress in diabetes through the PPAR/eNOS signaling pathway, providing new potential strategies for the treatment of diabetic vascular complications.